A recent study linked autoimmunity in a spontaneous mouse model of MS to the expression of the transforming growth factor beta (TGF-β) inhibitor, Smad7, in intestinal CD4+ T cells (132). The gene discussed is SMAD7; the disease is myeloid sarcoma.